§ Mr. LockTo ask the Secretary of State for Health what research he has commissioned into the safety of the drug, Lamotrigine. [67006]
§ Mr. DenhamAs for all marketed medicines, the available research into the safety of lamotrigine was assessed at the time of granting the marketing authorisation and continues to be evaluated by the Medicines Control Agency. Recognised side effects of lamotrigine are included in the authorised product information and the British National Formulary.
§ Mr. LockTo ask the Secretary of State for Health what representations have been made to his Department since the drug Lamotrigine was licensed for use in Britain, arising out of or related to the use of this drug or arising out of or connected to side effects suspected to be related to the use of this drug. [67005]
§ Mr. DenhamThe Medicines Control Agency, which is responsible for drug regulation in the United Kingdom, has received 35 inquiries relating to lamotrigine from health professionals and members of the public since the marketing authorisation was granted in 1991.